Tidal Investments’s Catalyst Pharmaceutical CPRX Stock Holding History

Tidal Investments’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.12M	Buy	+45,309	New	+$1.08M	﹤0.01%	1420
2025 Q4	–	Sell	-44,040	Closed	-$868K	–	2176
2025 Q3	$868K	Sell	44,040 -2,176	-5%	-$44.8K	﹤0.01%	1286
2025 Q2	$1M	Buy	46,216 +3,399	+8%	+$80.2K	0.01%	1033
2025 Q1	$1.04M	Buy	42,817 +4,676	+12%	+$105K	0.01%	964
2024 Q4	$796K	Sell	38,141 -1,905	-5%	-$40.9K	0.01%	1130
2024 Q3	$796K	Hold	40,046	–	–	0.01%	1120
2024 Q2	$620K	Buy	+40,046	New	+$623K	0.01%	1176

Other funds holding CPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Tidal Investments's CPRX Position: Q1 2026 in Review

Tidal Investments opened a new position in Catalyst Pharmaceutical (CPRX) in Q1 2026: 45,309 shares worth $1.12M. The stake represents ﹤0.01% of the portfolio and ranks #1420 among its holdings. This is a return to the name: Tidal Investments previously reported a position in CPRX as recently as Q3 2025.

Tidal Investments first reported a position in CPRX in Q2 2024 and has held it in 7 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

Tidal Investments held 45,309 shares of Catalyst Pharmaceutical worth $1.12M as of Q1 2026.
Catalyst Pharmaceutical was a new Tidal Investments position in Q1 2026.
Catalyst Pharmaceutical made up ﹤0.01% of Tidal Investments's portfolio in Q1 2026, its #1420 holding.
Tidal Investments first reported a position in Catalyst Pharmaceutical in Q2 2024 and has held it in 7 quarters since.
380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Tidal Investments's 13F filing for Q1 2026, filed 15 May 2026.